Skip to main content
SpringerLink
Log in

Organerhalt nach totaler neoadjuvanter Therapie beim Rektumkarzinom

Organ preservation after total neoadjuvant therapy in patients with rectal cancer

  • Journal Club
  • Published:
Die Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Benson AB, Venook AP, Al-Hawary MM et al (2020) NCCN guidelines insights: rectal cancer, version 6.2020. J Natl Compr Canc Netw 18:806–815

    Article  Google Scholar 

  2. Kang SB, Cho JR, Jeong SY et al (2021) Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): a long-term prospective, multicentre, cohort study. Lancet Reg Health West Pac 6:100087

    Article  Google Scholar 

  3. Peeters KC, van de Velde CJ, Leer JW et al (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol 23:6199–6206

    Article  CAS  Google Scholar 

  4. Cercek A, Roxburgh CSD, Strombom P et al (2018) Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol 4:e180071

    Article  Google Scholar 

  5. Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–718

    Article  Google Scholar 

  6. Appelt AL, Pløen J, Harling H et al (2015) High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 16:919–927

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Allgemein‑, Viszeral‑, Tumor- und Transplantationschirurgie, Universitätsklinikum Köln (AöR), Kerpener Str. 62, 50937, Köln, Deutschland

    Luca Fahrig &  Hakan Alakus

  2. Klinik I für Innere Medizin, Universitätsklinikum Köln, Köln, Deutschland

    Thomas Zander

Authors
  1. Luca Fahrig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Zander
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hakan Alakus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hakan Alakus.

Ethics declarations

Interessenkonflikt

L. Fahrig, T. Zander und H. Alakus geben an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fahrig, L., Zander, T. & Alakus, H. Organerhalt nach totaler neoadjuvanter Therapie beim Rektumkarzinom. Onkologie 28, 1022–1023 (2022). https://doi.org/10.1007/s00761-022-01241-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-022-01241-5

Search

Navigation